Cefminox

Cefminox (INN) is a second-generation cephalosporin antibiotic.[1][2]

Cefminox
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
IM, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC16H21N7O7S3
Molar mass519.57 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

Spectrum

Cefminox is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. The following represents MIC data for a few medically significant microorganisms.

  • Clostridium difficile: 2 - 4 µg/ml
  • Escherichia coli: 0.125 - 16 µg/ml
  • Pseudomonas aeruginosa: 256 µg/ml[3]

References

  1. Torres AJ, Valladares LD, Jover JM, Sánchez-Pernaute A, Frías J, Carcas AJ, et al. (September 2000). "Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trial". Infection. 28 (5): 318–22. doi:10.1007/s150100070027. PMID 11073141.
  2. US 8497086, "Reaction Medium For Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteria", issued 20 July 2013, assigned to Biomereux
  3. "Cefminox sodium Susceptibility and Minimum Inhibitory Concentration (MIC) Data" (PDF). www.toku-e.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.